DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Van Cutsem E. et al.
Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.
J Clin Oncol 2012;
30: 3499-3506
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.